Endothelin converting enzyme 1: Difference between revisions

Revision as of 11:00, 20 May 2009

Revision as of 20:04, 13 July 2010

Line 20:

*{{cite journal | author=Matsuoka R, Sawamura T, Yamada K, ''et al.'' |title=Human endothelin converting enzyme gene (ECE1) mapped to chromosomal region 1p36.1. |journal=Cytogenet. Cell Genet. |volume=72 |issue= 4 |pages= 322–4 |year= 1996 |pmid= 8641140 |doi=10.1159/000134214 }}

*{{cite journal | author=Orzechowski HD, Richter CM, Funke-Kaiser H, ''et al.'' |title=Evidence of alternative promoters directing isoform-specific expression of human endothelin-converting enzyme-1 mRNA in cultured endothelial cells. |journal=J. Mol. Med. |volume=75 |issue= 7 |pages= 512–21 |year= 1997 |pmid= 9253714 |doi=10.1007/s001090050136 }}

*{{cite journal | author=Schweizer A, Valdenaire O, Nelböck P, ''et al.'' |title=Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. |journal=Biochem. J. |volume=328 ( Pt 3) |issue= |pages= 871–7 |year= 1998 |pmid= 9396733 |doi= | pmc=1218999 }}

*{{cite journal | author=Kido T, Sawamura T, Masaki T |title=The processing pathway of endothelin-1 production. |journal=J. Cardiovasc. Pharmacol. |volume=31 Suppl 1 |issue= |pages= S13–5 |year= 1998 |pmid= 9595387 |doi=10.1097/00005344-199800001-00006 }}

*{{cite journal | author=Hofstra RM, Valdenaire O, Arch E, ''et al.'' |title=A loss-of-function mutation in the endothelin-converting enzyme 1 (ECE-1) associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction. |journal=Am. J. Hum. Genet. |volume=64 |issue= 1 |pages= 304–8 |year= 1999 |pmid= 9915973 |doi=10.1086/302184 | pmc=1377732 }}

*{{cite journal | author=Lee S, Lin M, Mele A, ''et al.'' |title=Proteolytic processing of big endothelin-3 by the kell blood group protein. |journal=Blood |volume=94 |issue= 4 |pages= 1440–50 |year= 1999 |pmid= 10438732 |doi= }}

*{{cite journal | author=Valdenaire O, Lepailleur-Enouf D, Egidy G, ''et al.'' |title=A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization. |journal=Eur. J. Biochem. |volume=264 |issue= 2 |pages= 341–9 |year= 1999 |pmid= 10491078 |doi=10.1046/j.1432-1327.1999.00602.x }}

Line 32:

*{{cite journal | author=Muller L, Barret A, Etienne E, ''et al.'' |title=Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease. |journal=J. Biol. Chem. |volume=278 |issue= 1 |pages= 545–55 |year= 2003 |pmid= 12393864 |doi= 10.1074/jbc.M208949200 }}

*{{cite journal | author=Eckman EA, Watson M, Marlow L, ''et al.'' |title=Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. |journal=J. Biol. Chem. |volume=278 |issue= 4 |pages= 2081–4 |year= 2003 |pmid= 12464614 |doi= 10.1074/jbc.C200642200 }}

*{{cite journal | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 }}

*{{cite journal | author=Masatsugu K, Itoh H, Chun TH, ''et al.'' |title=Shear stress attenuates endothelin and endothelin-converting enzyme expression through oxidative stress. |journal=Regul. Pept. |volume=111 |issue= 1-3 |pages= 13–9 |year= 2003 |pmid= 12609744 |doi=10.1016/S0167-0115(02)00219-7 }}

*{{cite journal | author=Smollich M, Götte M, Yip GW, ''et al.'' |title=On the role of endothelin-converting enzyme 1 (ECE-1) and neprilysin in human breast cancer. |journal=Breast Cancer Res. Treat. |volume=106 |issue= 3 |pages= 361–9 |year= 2007 |pmid= 17295044 |doi= 10.1007/s10549-007-9516-9 }}